Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.

about

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease.Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review

P2860

Q55387524-73D7D468-F37F-4107-9CA3-C09818271CDA Q55432750-B848E47D-9644-4028-B103-D1BF9886458A Q57483685-7C591DEB-99CB-4972-AD18-EBFA3DA2D1A0

P2860

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.

Item

http://www.wikidata.org/entity/Q38371555

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Long-Term Maintenance Bronchod ...... Patients: The FLIGHT 3 Study.

@en

type

Item

label

Long-Term Maintenance Bronchod ...... Patients: The FLIGHT 3 Study.

@en

prefLabel

Long-Term Maintenance Bronchod ...... Patients: The FLIGHT 3 Study.

@en

P1476

Long-Term Maintenance Bronchod ...... Patients: The FLIGHT 3 Study.

@en

P2093

Agnes A Schubert-Tennigkeit

http://www.w3.org/2001/XMLSchema#string

Angel Fowler Taylor

http://www.w3.org/2001/XMLSchema#string

Chau Thach

http://www.w3.org/2001/XMLSchema#string

Donald Banerji

http://www.w3.org/2001/XMLSchema#string

Francesco Patalano

http://www.w3.org/2001/XMLSchema#string

Gary T Ferguson

http://www.w3.org/2001/XMLSchema#string

Qian Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study

Deaths: Final Data for 2012.

The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.

Chronic obstructive pulmonary disease among adults--United States, 2011.

A novel model-based approach for dose determination of glycopyrronium bromide in COPD

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.

Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study.

Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety

P304

716-728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15326/JCOPDF.3.4.2016.0131

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28848898

http://www.w3.org/2001/XMLSchema#string

P932

5556955

http://www.w3.org/2001/XMLSchema#string

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.

about

P2860

P2860

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932